Hirano A - Search Results

1

Insulin-like growth factor-I enhances transforming growth factor-beta-induced extracellular matrix protein production through the P38/activating transcription factor-2 signaling pathway in keloid fibroblasts.

Daian T, Ohtsuru A, Rogounovitch T, Ishihara H, Hirano A, Akiyama-Uchida Y, Saenko V, Fujii T, Yamashita S. Daian T, et al. Among authors: hirano a. J Invest Dermatol. 2003 Jun;120(6):956-62. doi: 10.1046/j.1523-1747.2003.12143.x. J Invest Dermatol. 2003. PMID: 12787120 Free article.

2

DHMEQ, a novel NF-kappaB inhibitor, suppresses growth and type I collagen accumulation in keloid fibroblasts.

Makino S, Mitsutake N, Nakashima M, Saenko VA, Ohtsuru A, Umezawa K, Tanaka K, Hirano A, Yamashita S. Makino S, et al. Among authors: hirano a. J Dermatol Sci. 2008 Sep;51(3):171-80. doi: 10.1016/j.jdermsci.2008.03.003. Epub 2008 Apr 11. J Dermatol Sci. 2008. PMID: 18406579 Free article.

3

miR-196a downregulation increases the expression of type I and III collagens in keloid fibroblasts.

Kashiyama K, Mitsutake N, Matsuse M, Ogi T, Saenko VA, Ujifuku K, Utani A, Hirano A, Yamashita S. Kashiyama K, et al. Among authors: hirano a. J Invest Dermatol. 2012 Jun;132(6):1597-604. doi: 10.1038/jid.2012.22. Epub 2012 Feb 23. J Invest Dermatol. 2012. PMID: 22358059 Free article.

4

Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor.

Ishihara H, Yoshimoto H, Fujioka M, Murakami R, Hirano A, Fujii T, Ohtsuru A, Namba H, Yamashita S. Ishihara H, et al. Among authors: hirano a. J Invest Dermatol. 2000 Dec;115(6):1065-71. doi: 10.1046/j.1523-1747.2000.00180.x. J Invest Dermatol. 2000. PMID: 11121143 Free article.

5

Increased proliferative activity of osteoblasts in congenital hemifacial hypertrophy.

Yoshimoto H, Yano H, Kobayashi K, Hirano A, Motomura K, Ohtsuru A, Yamashita S, Fujii T. Yoshimoto H, et al. Among authors: hirano a. Plast Reconstr Surg. 1998 Oct;102(5):1605-10. doi: 10.1097/00006534-199810000-00041. Plast Reconstr Surg. 1998. PMID: 9774017

6

Mesenchymal stem cell therapy for cutaneous radiation syndrome.

Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S. Akita S, et al. Among authors: hirano a. Health Phys. 2010 Jun;98(6):858-62. doi: 10.1097/HP.0b013e3181d3d52c. Health Phys. 2010. PMID: 20445394 Free article.

7

Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury.

Akita S, Akino K, Hirano A, Ohtsuru A, Yamashita S. Akita S, et al. Among authors: hirano a. Stem Cells Int. 2010 Dec 1;2010:532704. doi: 10.4061/2010/532704. Stem Cells Int. 2010. PMID: 21151652 Free PMC article.

8

Leukemia inhibitory factor enhances bone formation in calvarial bone defect.

Dazai S, Akita S, Hirano A, Rashid MA, Naito S, Akino K, Fujii T. Dazai S, et al. Among authors: hirano a. J Craniofac Surg. 2000 Nov;11(6):513-20. doi: 10.1097/00001665-200011060-00002. J Craniofac Surg. 2000. PMID: 11314490

9

Early experiences with stem cells in treating chronic wounds.

Akita S, Yoshimoto H, Akino K, Ohtsuru A, Hayashida K, Hirano A, Suzuki K, Yamashita S. Akita S, et al. Among authors: hirano a. Clin Plast Surg. 2012 Jul;39(3):281-92. doi: 10.1016/j.cps.2012.04.005. Epub 2012 May 22. Clin Plast Surg. 2012. PMID: 22732376 Review.

10

Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy.

Suzuki K, Akita S, Yoshimoto H, Ohtsuru A, Hirano A, Yamashita S. Suzuki K, et al. Among authors: hirano a. Int J Mol Sci. 2019 Nov 5;20(21):5505. doi: 10.3390/ijms20215505. Int J Mol Sci. 2019. PMID: 31694186 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,313 results

Search Page

Filters